Review of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management

Nearly a billion adults around the world are affected by a disease that is characterized by upper airway collapse while sleeping called obstructive sleep apnea or OSA. The progression and lasting effects of untreated OSA include an increased risk of diabetes mellitus, hypertension, stroke, and heart...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ladan Panahi, George Udeani, Steven Ho, Brett Knox, Jason Maille
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	obstructive sleep apnea (OSA) pharmacotherapy Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/02393d22565a4149b9316269f0724fc8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:02393d22565a4149b9316269f0724fc8
record_format	dspace
spelling	oai:doaj.org-article:02393d22565a4149b9316269f0724fc82021-11-25T18:18:18ZReview of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management10.3390/medicina571111731648-91441010-660Xhttps://doaj.org/article/02393d22565a4149b9316269f0724fc82021-10-01T00:00:00Zhttps://www.mdpi.com/1648-9144/57/11/1173https://doaj.org/toc/1010-660Xhttps://doaj.org/toc/1648-9144Nearly a billion adults around the world are affected by a disease that is characterized by upper airway collapse while sleeping called obstructive sleep apnea or OSA. The progression and lasting effects of untreated OSA include an increased risk of diabetes mellitus, hypertension, stroke, and heart failure. There is often a decrease in quality-of-life scores and an increased rate of mortality in these patients. The most common and effective treatments for OSA include continuous positive airway pressure (CPAP), surgical treatment, behavior modification, changes in lifestyle, and mandibular advancement devices. There are currently no pharmacological options approved for the standard treatment of OSA. There are, however, some pharmacological treatments for daytime sleepiness caused by OSA. Identifying and treating obstructive sleep apnea early is important to reduce the risks of future complications.Ladan PanahiGeorge UdeaniSteven HoBrett KnoxJason MailleMDPI AGarticleobstructive sleep apnea (OSA)pharmacotherapyMedicine (General)R5-920ENMedicina, Vol 57, Iss 1173, p 1173 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	obstructive sleep apnea (OSA) pharmacotherapy Medicine (General) R5-920
spellingShingle	obstructive sleep apnea (OSA) pharmacotherapy Medicine (General) R5-920 Ladan Panahi George Udeani Steven Ho Brett Knox Jason Maille Review of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management
description	Nearly a billion adults around the world are affected by a disease that is characterized by upper airway collapse while sleeping called obstructive sleep apnea or OSA. The progression and lasting effects of untreated OSA include an increased risk of diabetes mellitus, hypertension, stroke, and heart failure. There is often a decrease in quality-of-life scores and an increased rate of mortality in these patients. The most common and effective treatments for OSA include continuous positive airway pressure (CPAP), surgical treatment, behavior modification, changes in lifestyle, and mandibular advancement devices. There are currently no pharmacological options approved for the standard treatment of OSA. There are, however, some pharmacological treatments for daytime sleepiness caused by OSA. Identifying and treating obstructive sleep apnea early is important to reduce the risks of future complications.
format	article
author	Ladan Panahi George Udeani Steven Ho Brett Knox Jason Maille
author_facet	Ladan Panahi George Udeani Steven Ho Brett Knox Jason Maille
author_sort	Ladan Panahi
title	Review of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management
title_short	Review of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management
title_full	Review of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management
title_fullStr	Review of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management
title_full_unstemmed	Review of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management
title_sort	review of the management of obstructive sleep apnea and pharmacological symptom management
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/02393d22565a4149b9316269f0724fc8
work_keys_str_mv	AT ladanpanahi reviewofthemanagementofobstructivesleepapneaandpharmacologicalsymptommanagement AT georgeudeani reviewofthemanagementofobstructivesleepapneaandpharmacologicalsymptommanagement AT stevenho reviewofthemanagementofobstructivesleepapneaandpharmacologicalsymptommanagement AT brettknox reviewofthemanagementofobstructivesleepapneaandpharmacologicalsymptommanagement AT jasonmaille reviewofthemanagementofobstructivesleepapneaandpharmacologicalsymptommanagement
_version_	1718411358613012480

Review of the Management of Obstructive Sleep Apnea and Pharmacological Symptom Management

Ejemplares similares